Literature DB >> 19724954

Inverse correlation between Skp2 and p27(Kip1) in normal endometrium and endometrial carcinoma.

Tsutomu Miyamoto1, Akiko Horiuchi, Hiroyasu Kashima, Akihisa Suzuki, Tomoko Yamada, Miyuki Kurai, Ikuo Konishi, Tanri Shiozawa.   

Abstract

Cyclin-dependent-kinase (cdk) inhibitor, p27(Kip1) (p27), has been shown to participate in progestin-induced growth suppression of normal endometrial glands. To analyse the molecular mechanisms regulating p27 protein, we examined immunohistochemical expression of the SCF(Skp2) (Skp1-Cullin-F-box protein) complex factors, i.e. Skp1, Cul1 and Skp2, and compared them with that of p27, steroid receptors and Ki-67. In normal endometrial glands, the expression of Skp2 was observed in the proliferative phase, whereas that of p27 was observed in the secretory phase. Cultured normal endometrial glandular cells showed that progesterone induced the down-regulation of Skp2 along with up-regulation of p27. In endometrial carcinomas, the inverse topological correlation between Skp2 and p27 was evident in 39/66 (59%) cases, and the expression of Skp2 showed a strong correlation with Ki-67. These findings suggest that the expression of SCF(Skp2) complex changes during the menstrual cycle in normal endometrium and the SCF(Skp2) ubiquitin-proteasome pathway may also work in endometrial carcinomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19724954     DOI: 10.1080/09513590903215482

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  6 in total

1.  TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.

Authors:  Savvas C Pavlides; Jon Lecanda; Julien Daubriac; Unnati M Pandya; Patricia Gama; Stephanie Blank; Khushbakhat Mittal; Pratibha Shukla; Leslie I Gold
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

2.  Skp2-RNAi suppresses proliferation and migration of gallbladder carcinoma cells by enhancing p27 expression.

Authors:  Bin Zhang; Lin-Hua Ji; Wei Liu; Gang Zhao; Zhi-Yong Wu
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

3.  Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.

Authors:  Kuang-Tzu Huang; Savvas C Pavlides; Jon Lecanda; Stephanie V Blank; Khushbakhat R Mittal; Leslie I Gold
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

4.  Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.

Authors:  Ying Luo; Dun-Quan Xu; Hai-Ying Dong; Bo Zhang; Yi Liu; Wen Niu; Ming-Qing Dong; Zhi-Chao Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

Review 5.  New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review).

Authors:  Kiyoko Umene; Kouji Banno; Iori Kisu; Megumi Yanokura; Yuya Nogami; Kosuke Tsuji; Kenta Masuda; Arisa Ueki; Yusuke Kobayashi; Wataru Yamagami; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Rep       Date:  2013-01-03       Impact factor: 3.906

6.  KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1.

Authors:  Mei-Ting Qiu; Qiong Fan; Zhu Zhu; Suet-Ying Kwan; Limo Chen; Jin-Hong Chen; Zuo-Lin Ying; Ye Zhou; Wei Gu; Li-Hua Wang; Wei-Wei Cheng; Jianfang Zeng; Xiao-Ping Wan; Samuel C Mok; Kwong-Kwok Wong; Wei Bao
Journal:  Oncotarget       Date:  2015-10-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.